Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 198.76 M201.77 M232.37 M185.75 M206.52 M 826.42 M Research & development ————— — Operating income 700.1 M837.42 M1.12 B545.71 M572.22 M 3.07 B Non-Operating Income, Total 92.15 M95 M109.57 M108.93 M286.11 M 599.62 M Interest expense, net of interest capitalized 329.79 M322.07 M324.88 M359.91 M379.74 M 1.39 B Non-Operating Income, excl. Interest Expenses -252.37 M-241.34 M-265.72 M-263.99 M-116.59 M -887.64 M Unusual income/expense 14.73 M14.27 M50.41 M13.02 M22.96 M 100.66 M Pretax income 462.46 M610.35 M903.73 M294.73 M478.6 M 2.29 B Equity in earnings ————— — Taxes 100.04 M138.4 M205.31 M54.2 M87.79 M 485.7 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 362.42 M471.95 M698.42 M240.53 M390.81 M 1.8 B Discontinued operations ————— — Net income 362.42 M471.95 M698.42 M240.53 M390.81 M 1.8 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 360.76 M467.93 M693.8 M235.78 M384.92 M 1.78 B Basic earnings per share (Basic EPS) 0.841.071.560.510.84 3.98 Diluted earnings per share (Diluted EPS) 0.821.051.530.510.83 3.92 Average basic shares outstanding 430.35 M434.79 M438.75 M442.03 M455.72 M — Diluted shares outstanding 440.65 M443.45 M447.25 M450.15 M462.51 M — EBITDA 1.27 B1.42 B1.7 B1.12 B1.17 B 5.41 B EBIT 700.1 M837.42 M1.12 B545.71 M572.22 M 3.07 B Cost of revenue 547.18 M526.79 M512.48 M501.53 M572.82 M 2.11 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 568.87 M579.15 M582.7 M574.85 M598.95 M 2.34 B